Literature DB >> 27830523

Pediatric Acute Myeloid Leukemia: Improved Survival Rates in India.

Rachna Seth1, Nivedita Pathak2, Amitabh Singh2, Anita Chopra3, Rajive Kumar3, M Kalaivani4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27830523     DOI： 10.1007/s12098-016-2234-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  6 in total

1.  Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

Authors:  Jeffrey E Rubnitz; Hiroto Inaba; Gary Dahl; Raul C Ribeiro; W Paul Bowman; Jeffrey Taub; Stanley Pounds; Bassem I Razzouk; Norman J Lacayo; Xueyuan Cao; Soheil Meshinchi; Barbara Degar; Gladstone Airewele; Susana C Raimondi; Mihaela Onciu; Elaine Coustan-Smith; James R Downing; Wing Leung; Ching-Hon Pui; Dario Campana
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

2.  Pediatric acute myeloid leukemia: final frontier for pediatric oncologists in developing world.

Authors:  Satya Prakash Yadav; Mohammed Ramzan; Meena Lall; Anupam Sachdeva
Journal:  Pediatr Hematol Oncol       Date:  2011-08-29       Impact factor: 1.969

Review 3.  Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

Authors:  Ursula Creutzig; Marry M van den Heuvel-Eibrink; Brenda Gibson; Michael N Dworzak; Souichi Adachi; Eveline de Bont; Jochen Harbott; Henrik Hasle; Donna Johnston; Akitoshi Kinoshita; Thomas Lehrnbecher; Guy Leverger; Ester Mejstrikova; Soheil Meshinchi; Andrea Pession; Susana C Raimondi; Lillian Sung; Jan Stary; Christian M Zwaan; Gertjan J L Kaspers; Dirk Reinhardt
Journal:  Blood       Date:  2012-08-09       Impact factor: 22.113

4.  Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.

Authors:  Ursula Creutzig; Martin Zimmermann; Thomas Lehrnbecher; Norbert Graf; Johann Hermann; Charlotte M Niemeyer; Alfred Reiter; Jörg Ritter; Michael Dworzak; Jan Stary; Dirk Reinhardt
Journal:  J Clin Oncol       Date:  2006-09-20       Impact factor: 44.544

5.  Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.

Authors:  Ichiro Tsukimoto; Akio Tawa; Keizo Horibe; Ken Tabuchi; Hisato Kigasawa; Masahiro Tsuchida; Hiromasa Yabe; Hideki Nakayama; Kazuko Kudo; Ryoji Kobayashi; Kazuko Hamamoto; Masue Imaizumi; Akira Morimoto; Shigeru Tsuchiya; Ryoji Hanada
Journal:  J Clin Oncol       Date:  2009-07-20       Impact factor: 44.544

6.  Acute Myeloid Leukemia in Children: Experience from Tertiary Cancer Centre in India.

Authors:  Venkatraman Radhakrishnan; Cherian Thampy; Prasanth Ganesan; Rejiv Rajendranath; Trivadi S Ganesan; K R Rajalekshmy; Tenali Gnana Sagar
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-18       Impact factor: 0.900
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.